Neurology and Cognitive Neuroscience

About us

The 36th International Conference on Neurology and Cognitive Neuroscience, scheduled for July 28–29, 2027, in Paris, France, is an international platform dedicated to advancing knowledge, research, clinical practice, and innovation in the fields of neurology and cognitive neuroscience. The conference brings together neurologists, neuroscientists, neurosurgeons, cognitive scientists, clinicians, researchers, academics, healthcare professionals, and industry experts from around the world to exchange knowledge, share experiences, and discuss the latest developments in brain and neurological sciences. The conference will explore a broad range of topics covering clinical neurology, cognitive neuroscience, neurodegenerative disorders, cerebrovascular diseases, epilepsy, movement disorders, neuroimmunology, neurogenetics, neuropsychiatry, neuroimaging, brain health, and emerging neurological therapies. Special attention will be given to technological and scientific developments that can support early diagnosis, personalized treatment, improved disease management, and better neurological outcomes.

The conference will also highlight modern approaches such as artificial intelligence, advanced neuroimaging, biomarkers, computational neuroscience, digital neurology, brain-computer interfaces, neurotechnology, precision medicine, and innovative therapeutic strategies. The 36th International Conference on Neurology and Cognitive Neuroscience aims to create a collaborative environment for scientific exchange and professional development while encouraging new ideas and interdisciplinary solutions for the challenges facing modern neurological care. Hosted in Paris, France, the conference provides an international setting for professionals to connect, collaborate, and contribute to the future of neurology and neuroscience. Through shared knowledge and interdisciplinary cooperation, the conference seeks to support advances in brain health, neurological diagnosis, treatment, rehabilitation, and cognitive science.

Sessions

Advances in Clinical Neurology and Brain Health

Recent developments in clinical neurology are improving the diagnosis, treatment, and management of neurological conditions. The session explores evidence-based practices, early diagnosis, personalized treatment, and integrated approaches to neurological care. Key challenges such as delayed diagnosis, treatment access, disease progression, and long-term patient management will be discussed. Emerging developments in neuroscience, digital healthcare, and precision medicine will also be highlighted. Experts will share research findings, clinical experiences, and innovative approaches from different areas of neurology. Multidisciplinary collaboration between neurologists, neuroscientists, researchers, rehabilitation specialists, and healthcare professionals will be encouraged. Discussions will focus on improving diagnostic accuracy, treatment effectiveness, accessibility, and quality of neurological care.

Neurodegenerative Diseases and Cognitive Disorders

Neurodegenerative diseases and cognitive disorders represent major challenges for patients, families, and healthcare systems. The session explores current approaches to the diagnosis, prevention, treatment, and management of conditions such as Alzheimer’s disease, Parkinson’s disease, dementia, and other progressive neurological disorders. Discussions will cover disease mechanisms, cognitive decline, biomarkers, neuroimaging, risk factors, pharmacological treatments, rehabilitation, and supportive care. Particular attention will be given to early detection, disease progression, cognitive assessment, and emerging therapeutic strategies. Advances in genetics, molecular neuroscience, artificial intelligence, and personalized medicine may provide new opportunities for understanding and managing neurodegenerative conditions. Experts will share clinical and research perspectives on improving neurological outcomes and quality of life.

Stroke and Cerebrovascular Disorders

Stroke and cerebrovascular diseases require rapid diagnosis, effective treatment, and coordinated long-term care. Discussions will focus on ischemic and hemorrhagic stroke, transient ischemic attacks, risk factors, acute management, prevention, and neurological rehabilitation. Advances in neuroimaging, thrombolytic therapy, thrombectomy, biomarkers, and digital monitoring will also be explored. Attention will be given to stroke prevention, secondary prevention, rehabilitation, cognitive consequences, and recovery. Emerging technologies and data-driven approaches may support faster diagnosis and improved treatment decisions. Collaboration among neurologists, radiologists, emergency physicians, rehabilitation specialists, and researchers will be encouraged to advance comprehensive stroke care.

Epilepsy and Seizure Disorders

Epilepsy and seizure disorders require accurate diagnosis and individualized long-term management. The session explores seizure classification, diagnostic evaluation, electroencephalography, neuroimaging, medication management, drug-resistant epilepsy, and surgical treatment options. Discussions will address seizure monitoring, treatment adherence, safety, quality of life, and neurological outcomes. Emerging approaches including wearable technologies, artificial intelligence, advanced EEG analysis, neurostimulation, and personalized treatment may provide new opportunities for epilepsy care. Experts will discuss clinical experiences and research developments aimed at improving diagnosis, treatment selection, seizure control, and patient support.

Movement Disorders and Parkinsonian Syndromes

Movement disorders affect motor function, cognition, communication, and quality of life. The session focuses on Parkinson’s disease, essential tremor, dystonia, Huntington’s disease, ataxia, and other movement-related neurological conditions. Discussions will cover clinical assessment, disease mechanisms, biomarkers, pharmacological treatment, rehabilitation, and advanced therapeutic approaches. Deep brain stimulation, wearable technologies, digital biomarkers, neuroimaging, and artificial intelligence may provide new opportunities for monitoring and personalized management. Multidisciplinary care involving neurologists, neurosurgeons, physiotherapists, occupational therapists, speech specialists, and researchers will be highlighted.

Neuroscience and Neurobiology of Neurological Disorders

Advances in neuroscience are providing deeper insights into the biological mechanisms underlying neurological diseases. The session explores neural circuits, neurotransmitter systems, neuroplasticity, genetics, epigenetics, inflammation, and interactions between biological and environmental factors. Research related to neurodegenerative diseases, epilepsy, stroke, movement disorders, cognitive impairment, and neurodevelopmental conditions will be considered. Brain imaging, biomarkers, molecular research, and computational neuroscience may offer new opportunities for understanding disease mechanisms. Discussions will examine how scientific discoveries can be translated into improved diagnostic and therapeutic approaches. Collaboration between neurologists, neuroscientists, geneticists, imaging specialists, and researchers will be encouraged.

Cognitive Neuroscience and Brain Function

Cognitive neuroscience provides important insights into how the brain supports memory, attention, language, learning, decision-making, perception, and behavior. The session explores relationships between neural activity, cognition, brain networks, and human behavior. Topics will include memory systems, executive function, attention, language processing, cognitive development, and age-related cognitive changes. Neuroimaging, electrophysiology, computational modeling, and experimental neuroscience will be discussed as tools for understanding brain function. Researchers will examine how cognitive neuroscience findings can contribute to neurological diagnosis, rehabilitation, and personalized approaches to cognitive health.

Neuroimaging, Biomarkers and Advanced Diagnostics

Advances in neuroimaging, molecular research, electrophysiology, and biomarker discovery are creating new opportunities for neurological diagnosis and research. The session explores MRI, functional MRI, PET, CT, EEG, electrophysiological techniques, genetic markers, molecular biomarkers, and other emerging diagnostic approaches. These technologies may contribute to improved understanding of disease mechanisms, early detection, prognosis, and treatment response. Researchers will discuss applications across neurological and cognitive disorders. Challenges including reproducibility, validation, cost, accessibility, and clinical interpretation will also be considered. Collaboration among neurology, neuroscience, radiology, genetics, and data science will be encouraged.

Artificial Intelligence and Technology in Neurology

Artificial intelligence and advanced technologies are creating new possibilities across neurological diagnosis, clinical decision support, monitoring, prediction, and personalized care. The session explores emerging applications of AI, machine learning, natural-language processing, computer vision, and data analytics in neurology and neuroscience. Discussions will address automated imaging analysis, digital biomarkers, disease prediction, remote monitoring, and technology-supported clinical decision-making. Data quality, algorithmic bias, transparency, privacy, cybersecurity, and clinical validation will also receive attention. Experts will consider how emerging technologies can complement healthcare professionals while maintaining appropriate clinical oversight and patient safety.

Neurotechnology, Brain-Computer Interfaces and Digital Neurology

Rapid developments in neurotechnology are creating new opportunities for neurological research, diagnosis, rehabilitation, and patient care. The session explores brain-computer interfaces, neural implants, wearable devices, digital biomarkers, remote monitoring, neurostimulation, and assistive technologies. Discussions will consider applications in movement disorders, paralysis, epilepsy, rehabilitation, cognitive disorders, and other neurological conditions. The potential of digital tools to support continuous monitoring and personalized care will also be examined. Ethical considerations, data privacy, accessibility, safety, and clinical implementation will remain important areas of discussion.

Multiple Sclerosis and Neuroimmunology

Multiple sclerosis and other neuroimmune disorders involve complex interactions between the immune system and nervous system. The session explores disease mechanisms, diagnosis, biomarkers, imaging, disease-modifying therapies, relapse management, and long-term patient care. Discussions will also address autoimmune encephalitis, neuromyelitis optica spectrum disorders, and other inflammatory neurological conditions. Advances in immunology, genetics, neuroimaging, and personalized treatment may contribute to improved disease management. Experts will discuss emerging therapies, treatment monitoring, rehabilitation, and strategies for improving quality of life.

Neuromuscular Disorders and Peripheral Neurology

Neuromuscular disorders can affect nerves, muscles, neuromuscular junctions, and motor neurons, leading to significant functional limitations. The session covers conditions such as peripheral neuropathies, myasthenia gravis, muscular dystrophies, motor neuron diseases, and other neuromuscular disorders. Discussions will focus on clinical assessment, electrophysiological diagnosis, genetics, biomarkers, pharmacological treatment, rehabilitation, and emerging therapies. Advances in gene-based therapies, molecular diagnostics, and precision medicine may provide new opportunities for patients with rare and complex neuromuscular conditions.

Headache, Migraine and Pain Neurology

Headache disorders and migraine are common neurological conditions that can significantly affect daily functioning and quality of life. The session explores migraine, tension-type headache, cluster headache, chronic headache, and other neurological pain conditions. Discussions will cover diagnosis, triggers, preventive strategies, acute treatment, medication safety, lifestyle factors, and emerging therapies. New developments in neurobiology, biomarkers, digital monitoring, neuromodulation, and personalized treatment approaches will also be considered. Experts will share clinical and research perspectives on improving headache management and patient outcomes.

Neurological Rehabilitation and Neuroplasticity

Neurological rehabilitation plays an important role in improving functional recovery and quality of life following neurological injury or disease. The session explores neuroplasticity, physical rehabilitation, occupational therapy, speech and language therapy, cognitive rehabilitation, and assistive technologies. Discussions will address recovery following stroke, traumatic brain injury, spinal cord injury, and other neurological conditions. Emerging technologies such as robotics, virtual reality, wearable devices, brain-computer interfaces, and digital rehabilitation platforms may provide additional opportunities for personalized rehabilitation. Multidisciplinary approaches will be highlighted.

Precision Neurology and Personalized Brain Care

Precision neurology is emerging as an approach that considers individual biological, genetic, clinical, environmental, and behavioral characteristics in neurological care. The session explores biomarkers, genetics, neuroimaging, digital phenotyping, patient-reported outcomes, and data-driven approaches. Personalized strategies may support earlier diagnosis, improved disease classification, and more targeted treatment decisions. Discussions will also address data quality, validation, accessibility, privacy, ethics, and health equity. Collaboration between neurology, neuroscience, genetics, imaging, pharmacology, and data science will be encouraged.

Market Analysis

The market for neurology, neuroscience, neurological diagnostics, therapeutics, and brain health is developing alongside increasing attention to the growing burden of neurological disorders and the need for improved diagnosis, treatment, rehabilitation, and long-term care. The field includes pharmaceutical and biotechnology companies, medical device manufacturers, diagnostic organizations, healthcare institutions, research centers, digital health companies, and academic institutions working toward new solutions for neurological and cognitive conditions. Advances in biomarkers, molecular diagnostics, neuroimaging, genetics, neurostimulation, rehabilitation technologies, and personalized medicine are contributing to the development of new clinical and research opportunities.

Technology is becoming an increasingly important component of modern neurological care. Artificial intelligence, machine learning, digital biomarkers, wearable devices, tele-neurology, remote monitoring, brain-computer interfaces, advanced imaging, and data-driven personalized care are creating new possibilities for improving neurological assessment and extending care beyond traditional clinical settings. These developments are also encouraging collaboration between neurologists, neuroscientists, engineers, data scientists, pharmaceutical companies, biotechnology organizations, and digital health providers. Alongside technological innovation, there is increasing interest in precision neurology, neuroimaging, biomarkers, cognitive neuroscience, neurogenetics, neuroplasticity, neurorehabilitation, neurotechnology, artificial intelligence, and emerging neurological therapies. These developments create opportunities for scientific collaboration, technology development, clinical research, and professional exchange.

Past Conference Report

Cognitive Neuroscience 2025

The market for neurology, neuroscience, neurological diagnostics, therapeutics, and brain health is developing alongside increasing attention to the growing burden of neurological disorders and the need for improved diagnosis, treatment, rehabilitation, and long-term care. The field includes pharmaceutical and biotechnology companies, medical device manufacturers, diagnostic organizations, healthcare institutions, research centers, digital health companies, and academic institutions working toward new solutions for neurological and cognitive conditions. Advances in biomarkers, molecular diagnostics, neuroimaging, genetics, neurostimulation, rehabilitation technologies, and personalized medicine are contributing to the development of new clinical and research opportunities. Technology is becoming an increasingly important component of modern neurological care. Artificial intelligence, machine learning, digital biomarkers, wearable devices, tele-neurology, remote monitoring, brain-computer interfaces, advanced imaging, and data-driven personalized care are creating new possibilities for improving neurological assessment and extending care beyond traditional clinical settings. These developments are also encouraging collaboration between neurologists, neuroscientists, engineers, data scientists, pharmaceutical companies, biotechnology organizations, and digital health providers. Alongside technological innovation, there is increasing interest in precision neurology, neuroimaging, biomarkers, cognitive neuroscience, neurogenetics, neuroplasticity, neurorehabilitation, neurotechnology, artificial intelligence, and emerging neurological therapies. These developments create opportunities for scientific collaboration, technology development, clinical research, and professional exchange.